[{"Assets_0_Q2_USD":103793000.0,"CommonStockSharesOutstanding_0_Q2_shares":11885524.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-9653000.0,"NetIncomeLoss_1_Q2_USD":-7090000.0,"NetIncomeLoss_2_Q2_USD":-13226000.0,"StockholdersEquity_0_Q2_USD":85597000.0,"Ticker":"GEVO","CIK":"1392380","name":"GEVO, INC.","OfficialName":"Gevo Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"886730226.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190814"}]